Equivalence of paper and electronic-based patient reported outcome measures for children: a systematic review, February 2023 JPGN

Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children, February 2023 JPGN

Fecal Elastase in Preterm Infants to Predict Growth Outcomes, February 2023 JPGN

Characterizing the Pain Experience of Children with Acute Gastroenteritis Based on Identified Pathogens, February 2023 JPGN

Perioperative Management of Pediatric Crohn’s Disease, February 2023 JPGN

Bowel Sounds: Joel Rosh, MD –  Biologics and Small Molecules Beyond Anti-TNF for treating IBD

In this episode, Dr. Peter Lu and Dr. Jennifer Lee talk to Dr. Joel Rosh about how treatment advances in pediatric inflammatory bowel disease. Dr. Rosh is Chief of Pediatric Gastroenterology, Liver Diseases and Nutrition at Cohen Children’s Medical Center, Northwell Health. He is a national board member for the Crohn’s and Colitis Foundation. We discuss the the different classes of biologic and small molecules used in the treatment of pediatric inflammatory bowel disease including tips on insurance approval, challenging clinical scenarios, and biosimilar medications.

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

Bowel Sounds: John Fortunato, MD - POTS, Dysautonomia, and Pediatric GI

In this episode, Dr. Peter Lu and Dr. Jason Silverman talk to Dr. John Fortunato about orthostatic intolerance, postural orthostatic tachycardia syndrome (POTS), dysautonomia, and why we are seeing these issues more and more often in our GI practices. Dr. Fortunato is Director of the Neurointestinal and Motility Program at Lurie Children's Hospital and Professor of Pediatrics at the Northwestern University Feinberg School of Medicine. He explains how we can recognize these disorders and provides practical guidance on management.

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

Children with cholestatic liver diseases have unique nutritional requirements. Without bile reaching their intestines, they often suffer from fat-malabsorption and associated consequences. As a result, they require formulas with special fat preparations, as well as intensive monitoring to ensure adequate growth. They also often have fat-soluble vitamin deficiencies requiring aggressive supplementation. In this webinar, nutritional considerations in children with cholestasis will be discussed, with special emphasis on nutritional support and vitamin/micronutrient deficiencies.

Supported by educational grants from Albireo, Mirum and Travere.

Effect of caffeine on patients undergoing Colonic motility testing, January 2023 JPGN

Health Care Transition for Adolescents and Young Adults with Pediatric-Onset Liver Disease and Transplantation: A Position Paper by NASPGHAN, January 2023 JPGN